Myriad has no more right to patent these parts of the naturally occurring code in the human genome than it would to patent an apple, or a branch off of a tree that could be used to hit a ball or scratch your back, Ravicher says.
Myriad objects to the comparison of the gene sequences with a branch or an apple off of a tree, and its lawyers convinced a majority of the judges on the Federal Circuit to agree.